SC 13G

Company

Ascendis Pharma A/S

Filed

February 9, 2016

Accession Number

0001104659-16-094997

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →